Dr. Insight provides a novel systematic connectivity mapping method to connect drugs (compounds) in CMap database with query data (disease phenotype or new drug profile). The Dr. Insight package contains two components of drug repurposing analyses: (1) Drug identification analysis to identify drugs that may reverse the disease phenotype (negative connectivity) or have similar functions with a query drug (positive connectivity); (2) Pathway analysis reveals drug mechanism of action at the pathway and gene level.
Access Dr. Insight
Citation: Jinyan Chan, Xuan Wang, Jacob A Turner, Nicole E Baldwin, Jinghua Gu, Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing, Bioinformatics, Volume 35, Issue 16, 15 August 2019, Pages 2818–2826, https://doi.org/10.1093/bioinformatics/btz006